These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels. Lee AW; Wang N; Hornell TM; Harding JJ; Deshpande C; Hertel L; Lacaille V; Pashine A; Macaubas C; Mocarski ES; Mellins ED Mol Immunol; 2011 May; 48(9-10):1160-7. PubMed ID: 21458073 [TBL] [Abstract][Full Text] [Related]
25. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells. Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734 [TBL] [Abstract][Full Text] [Related]
26. Expression of HLA-DRA and CD74 mRNA in whole blood during the course of complicated and uncomplicated Staphylococcus aureus bacteremia. Rasmussen G; Cajander S; Bäckman A; Källman J; Söderquist B; Strålin K Microbiol Immunol; 2017 Oct; 61(10):442-451. PubMed ID: 28862321 [TBL] [Abstract][Full Text] [Related]
27. HLA-DRA polymorphisms associated with risk of nasal polyposis in asthmatic patients. Kim JH; Park BL; Cheong HS; Pasaje CF; Bae JS; Park JS; Uh ST; Kim YH; Kim MK; Choi IS; Choi BW; Park CS; Shin HD Am J Rhinol Allergy; 2012; 26(1):12-7. PubMed ID: 22391069 [TBL] [Abstract][Full Text] [Related]
28. HLA-DR and DQ antigens in chronic lymphocytic leukemia: dissociation of expression revealed by cell surface, protein, and mRNA studies. Kraïba R; Loiseau P; Faille A; Poirier O; Piatier-Tonneau D; Degos L; Abita JP; Charron D Leukemia; 1989 May; 3(5):386-93. PubMed ID: 2497283 [TBL] [Abstract][Full Text] [Related]
29. Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides. Pashine A; Busch R; Belmares MP; Munning JN; Doebele RC; Buckingham M; Nolan GP; Mellins ED Immunity; 2003 Aug; 19(2):183-92. PubMed ID: 12932352 [TBL] [Abstract][Full Text] [Related]
31. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients. Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327 [TBL] [Abstract][Full Text] [Related]
32. T-cell repertoire in a strain of transgenic C57BL/6 mice with the HLA-DRA gene on the X-chromosome. Fukui Y; Esaki Y; Kimura A; Hirokawa K; Nishimura Y; Sasazuki T Immunogenetics; 1993; 37(3):204-11. PubMed ID: 8420827 [TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor alpha response elements in the HLA-DRA promoter: identification of a tumor necrosis factor alpha-induced DNA-protein complex in astrocytes. Panek RB; Moses H; Ting JP; Benveniste EN Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11518-22. PubMed ID: 1454841 [TBL] [Abstract][Full Text] [Related]
34. Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation. Osborne A; Zhang H; Yang WM; Seto E; Blanck G Mol Cell Biol; 2001 Oct; 21(19):6495-506. PubMed ID: 11533238 [TBL] [Abstract][Full Text] [Related]
35. Mapping of the interaction site of the defective transcription factor in the class II major histocompatibility complex mutant cell line clone-13 to the divergent X2-box. Ono SJ; Song Z J Biol Chem; 1995 Mar; 270(11):6396-402. PubMed ID: 7890777 [TBL] [Abstract][Full Text] [Related]
36. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma. Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221 [TBL] [Abstract][Full Text] [Related]
37. Regulation of HLA-DR gene by IFN-gamma. Transcriptional and post-transcriptional control. Rosa FM; Fellous M J Immunol; 1988 Mar; 140(5):1660-4. PubMed ID: 3126233 [TBL] [Abstract][Full Text] [Related]
38. Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFα response: A diagnostic tool for immunosuppression? Winkler MS; Rissiek A; Priefler M; Schwedhelm E; Robbe L; Bauer A; Zahrte C; Zoellner C; Kluge S; Nierhaus A PLoS One; 2017; 12(8):e0182427. PubMed ID: 28771573 [TBL] [Abstract][Full Text] [Related]
39. 5'-UTR mediated translational control of splicing assembly factor RNP-4F expression during development of the Drosophila central nervous system. Chen J; Yang JT; Doctor DL; Rawlins BA; Shields BC; Vaughn JC Gene; 2013 Oct; 528(2):154-62. PubMed ID: 23892091 [TBL] [Abstract][Full Text] [Related]
40. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]